These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 32856226)

  • 1. Comparison of Blood Glucose Variability Between Exenatide and Biphasic Insulin Aspart 30 in Chinese Participants with Type 2 Diabetes Inadequately Controlled with Metformin Monotherapy: A Multicenter, Open-Label, Randomized Trial.
    Wang L; Liu X; Yang W; Lai J; Yu X; Liu J; Gao X; Ming J; Ma K; Xu J; Tian Z; He Q; Ji Q
    Diabetes Ther; 2020 Oct; 11(10):2313-2328. PubMed ID: 32856226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of exenatide with biphasic insulin aspart 30 on glucose variability in type 2 diabetes: study protocol for a randomized controlled trial.
    Xu S; Liu X; Ming J; Ji Q
    Trials; 2016 Mar; 17():160. PubMed ID: 27009108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 28-week, randomized, multicenter, open-label, parallel-group phase III trial to investigate the efficacy and safety of biphasic insulin aspart 70 thrice-daily injections vs twice-daily injections of biphasic insulin aspart 30 in patients with type 2 diabetes.
    Kadowaki T; Nishida T; Kaku K
    J Diabetes Investig; 2010 Jun; 1(3):103-10. PubMed ID: 24843416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of a twice daily injection of insulin aspart 50 with insulin aspart 30 in patients with poorly controlled type 2 diabetes.
    Shi C; Sun L; Bai R; Wang H; Liu D; Du J
    Curr Med Res Opin; 2019 Jun; 35(6):1091-1096. PubMed ID: 30550344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of Glycemic Variability in Chinese T2DM Patients Treated with Exenatide or Insulin Glargine: A Randomized Controlled Trial.
    Yin TT; Bi Y; Li P; Shen SM; Xiong XL; Gao LJ; Jiang C; Wang Y; Feng WH; Zhu DL
    Diabetes Ther; 2018 Jun; 9(3):1253-1267. PubMed ID: 29744819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of biphasic insulin aspart 70/30 versus exenatide in subjects with type 2 diabetes failing to achieve glycemic control with metformin and a sulfonylurea.
    Bergenstal R; Lewin A; Bailey T; Chang D; Gylvin T; Roberts V;
    Curr Med Res Opin; 2009 Jan; 25(1):65-75. PubMed ID: 19210140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biphasic insulin aspart 30: better glycemic control than with premixed human insulin 30 in obese patients with Type 2 diabetes.
    Velojic-Golubovic M; Mikic D; Pesic M; Dimic D; Radenkovic S; Antic S
    J Endocrinol Invest; 2009 Jan; 32(1):23-7. PubMed ID: 19337010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the pharmacokinetic and pharmacodynamic profiles of biphasic insulin aspart 50 and 30 in patients with type 2 diabetes mellitus: a single-center, randomized, double-blind, two-period, crossover trial in Japan.
    Hirao K; Maeda H; Urata S; Takisawa Y; Hirao S; Sasako T; Sasaki T
    Clin Ther; 2007 May; 29(5):927-934. PubMed ID: 17697911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Acarbose on Glycemic Variability in Patients with Poorly Controlled Type 2 Diabetes Mellitus Receiving Stable Background Therapy: A Placebo-Controlled Trial.
    Derosa G; Franzetti I; Querci F; D'Angelo A; Maffioli P
    Pharmacotherapy; 2015 Nov; 35(11):983-90. PubMed ID: 26598090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adding biphasic insulin aspart 30 once or twice daily is more efficacious than optimizing oral antidiabetic treatment in patients with type 2 diabetes.
    Bebakar WM; Chow CC; Kadir KA; Suwanwalaikorn S; Vaz JA; Bech OM;
    Diabetes Obes Metab; 2007 Sep; 9(5):724-32. PubMed ID: 17593237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acarbose-metformin is more effective in glycemic variability control than repaglinide-metformin in T2DM patients inadequately controlled with metformin: a retrospective cohort study.
    Du G; Xie W; Su Y; Ma Y; Gao X; Jiang S; Liang H
    PeerJ; 2020; 8():e9905. PubMed ID: 33072435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of Premixed Human Insulin 30/70 to Biphasic Aspart 30 in Well-Controlled Patients with Type 2 Diabetes Using Continuous Glucose Monitoring.
    Margaritidis C; Karlafti E; Kotzakioulafi E; Kantartzis K; Tziomalos K; Kaiafa G; Savopoulos C; Didangelos T
    J Clin Med; 2021 May; 10(9):. PubMed ID: 34063071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the effects of twice-daily exenatide and insulin on carotid intima-media thickness in type 2 diabetes mellitus patients: a 52-week randomized, open-label, controlled trial.
    Zhang J; Xian TZ; Wu MX; Li C; Pan Q; Guo LX
    Cardiovasc Diabetol; 2020 Apr; 19(1):48. PubMed ID: 32334592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of Efficacy and Economic Value of Prandilin 25 and Humalog Mix 25 in Patients with Newly Diagnosed Type 2 Diabetes by a Continuous Glucose Monitoring System.
    Luo Y; Wang XQ; Ni WJ; Ding B; Xu XH; Ye L; Ma JH; Zhu J
    Diabetes Ther; 2018 Dec; 9(6):2219-2228. PubMed ID: 30244319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Characteristics of glycemic excursion in different subtypes of impaired glucose intolerance].
    Kang Y; Lu JM; Sun JF; Li CL; Wang XL; Zhang XQ; Lü ZH; Dou JT; Mu YM
    Zhonghua Yi Xue Za Zhi; 2009 Mar; 89(10):669-72. PubMed ID: 19595059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of Efficacy and Safety of Lispro and Aspart Evaluated by Continuous Glucose Monitoring System in Patients with Newly Diagnosed Type 2 Diabetes.
    Liu BL; Yin GP; Li FF; Hu Y; Wu JD; Chen MY; Ye L; Su XF; Ma JH
    Int J Endocrinol; 2018; 2018():2087960. PubMed ID: 29780415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exenatide once weekly improved 24-hour glucose control and reduced glycaemic variability in metformin-treated participants with type 2 diabetes: a randomized, placebo-controlled trial.
    Frías JP; Nakhle S; Ruggles JA; Zhuplatov S; Klein E; Zhou R; Strange P
    Diabetes Obes Metab; 2017 Jan; 19(1):40-48. PubMed ID: 27527911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Twice-daily biphasic insulin aspart 30 versus biphasic human insulin 30: a double-blind crossover study in adults with type 2 diabetes mellitus.
    McSorley PT; Bell PM; Jacobsen LV; Kristensen A; Lindholm A
    Clin Ther; 2002 Apr; 24(4):530-9. PubMed ID: 12017398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exenatide once weekly combined with metformin reduced glycemic variability in type 2 diabetes by using flash glucose monitoring system.
    Li Y; Han MM; He Q; Liu ZA; Liang D; Hou JT; Zhang Y; Liu YF
    World J Diabetes; 2020 Dec; 11(12):654-665. PubMed ID: 33384771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of exenatide on 24-hour blood glucose profile compared with placebo in patients with type 2 diabetes: a randomized, double-blind, two-arm, parallel-group, placebo-controlled, 2-week study.
    Schwartz SL; Ratner RE; Kim DD; Qu Y; Fechner LL; Lenox SM; Holcombe JH
    Clin Ther; 2008 May; 30(5):858-67. PubMed ID: 18555933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.